Gerald via Twitter. Big update on near term objec
Post# of 1418
Big update on near term objectives.
$TOMDF 3CL Pharma will also look at Tollovid in acute COVID in healthy and pediatric, both places Paxlovid doesn’t work / can’t be used. Prevention of in-house transmission also on table now as just approached by Israel HMOs on this. Expect Tollovid green light in Israel soon /1
https://twitter.com/G_Commish/status/15744181...w&s=19
TOMDF Getting ready to submit EUA for our #MonkeyPox saliva test. Need a 2 more early infection patients to wrap up FDA validation. If any newly diagnosed patients out there please reach out. You’ll be helping to get first approved pre-symptomatic test on to the market. Thanks!
!https://twitter.com/G_Commish/status/1574418703906754560?t=5O3TD9OytpNqghia-55Uhw&s=19
This is all in addition to Tollovid in #LongCOVID and Tollovir in hospital, acute (immune compromised), pediatric and Long COVID. TolloTest plans now coming together nicely as companion then standalone. 3CL crowdfunding open soon.
https://twitter.com/G_Commish/status/15744160...w&s=19